HIF1A and ovarian cancer: Inhibition of HIF-α expression delayed the progression of certain types of cancers such as colon cancer and ovarian cancer [6,7], indicating that the inhibition of HIF-1α expression may serve as a potential therapeutic target for different types of malignancies.